Table 3. Summary of post-immunization laboratory abnormalities by parameter and grade for subjects in both cohorts by true and mock groups over all five immunizations.
Cohort 1 | Cohort 2 | |||||||
---|---|---|---|---|---|---|---|---|
True Immunized N = 13 | Mock Immunized N = 4 | True Immunized N = 12 | Mock Immunized N = 4 | |||||
Lab test (units) | Grade 1 n (%) | Grade 2 n (%) | Grade 1 n (%) | Grade 2 n (%) | Grade 1 n (%) | Grade 2 n (%) | Grade 1 n (%) | Grade 2 n (%) |
Any immunization | ||||||||
ALP (U/L) | 1 (7.7) | 0 | 1 (25) | 0 | 0 | 0 | 0 | 0 |
ALT (U/L) | 6 (46.2) | 0 | 2 (50) | 1 (25) | 4 (33.3) | 1 (8.3) | 1 (25) | 0 |
AST (U/L) | 3 (23.1) | 2 (15.4) | 1 (25) | 1 (25) | 3 (25) | 1 (8.3) | 0 | 0 |
BUN (mg/dL) | 4 (30.8) | 2 (50) | 2 (50) | 0 | 1 (8.3) | 0 | 2 (50) | 0 |
Creatinine (mg/dL) | 3 (23.1) | 1 (7.7) | 2 (50) | 0 | 3 (25) | 0 | 2 (50) | 0 |
Eosinophils (cells/uL) | 1 (7.7) | 1 (7.7) | 0 | 0 | 2 (16.7) | 0 | 0 | 0 |
Hemoglobin (g/dL) | 0 | 3 (23.1) | 2 (50) | 0 | 0 | 0 | 0 | 0 |
Lymphocytes (cells/uL) | 3 (23.1) | 3 (23.1) | 1 (25) | 3 (75) | 2 (16.7) | 0 | 0 | 0 |
Neutrophils (cells/uL) | 3 (23.1) | 2 (15.4) | 1 (25) | 1 (25) | 0 | 0 | 0 | 0 |
Platelets (10x3/uL) | 1 (7.7) | 2 (15.4) | 1 (25) | 0 | 0 | 0 | 0 | 0 |
Total bilirubin (mg/dL) | 2 (15.4) | 0 | 0 | 0 | 1 (8.3) | 0 | 0 | 0 |
WBC (10x3/uL) | 5 (38.5) | 1 (7.7) | 1 (25) | 1 (25) | 3 (25) | 0 | 0 | 0 |
Column header counts and denominators are the number of subjects who received at least one immunization.
Subjects with at least one abnormal lab within 7 days of any immunization are presented.
A subject is counted once per row.
No Grade 3 or 4 severity lab abnormalities were reported.